Literature DB >> 8549318

In vitro susceptibility of mycoplasmas to a new quinolone, BAY Y 3118.

H Renaudin1, C Bébéar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549318     DOI： 10.2165/00003495-199500492-00056

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  4 in total

1.  Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Authors:  K B Waites; L B Duffy; T Schmid; D Crabb; M S Pate; G H Cassell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 3.  Activity of quinolones against mycobacteria.

Authors:  M R Jacobs
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].

Authors:  C Bebear; P Cantet; H Renaudin; C Quentin
Journal:  Pathol Biol (Paris)       Date:  1985-06
  4 in total
  1 in total

1.  In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas.

Authors:  C M Bébéar; H Renaudin; A Boudjadja; C Bébéar
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.